Pharmacies, Drugmakers on Edge for Rollout of US Drug Price Cuts

Major drugmakers and pharmacy groups are weighing how they will implement the first Medicare negotiated drug prices amid concerns about reimbursement practices and the impact of pharmacy benefit managers on how prices reach eligible individuals.

The Biden administration this month reached a milestone in its Medicare Drug Price Negotiation Program when it published the negotiated prices of 10 prescription drugs after months of talks between manufacturers and the Medicare agency. The negotiations stemmed from the administration’s efforts to lower drug costs under President Joe Biden‘s signature Inflation Reduction Act.

The negotiated prices, which the statute refers to as maximum ...